Electroceramics are advanced ceramic materials that exhibit electronic, optical or electro-magnetic properties. Electroceramic materials are used for specific technological applications, which include the manufacture of data storage devices, sensors, transducers, and actuators. Electroceramic materials can be divided into multiple subclasses, with each subclass being used for specific applications. Major materials for electroceramics include titanate, zirconia, alumina, and others. Titanate is a base material in piezoelectric ceramics, while alumina is used to develop metrology components, actuators, semiconductor cores, and substrates. Semiconducting oxides are used for environment monitoring, in magnetic ceramic materials, which are used for data storage, and ferroelectric materials, which are used to develop accelerometers. Due to their increase in their demand, the consumption of electroceramics is expected to increase in the near future.
The global market for Ovarian Cancer Diagnostics was estimated to be worth US$ 1054.2 million in 2023 and is forecast to a readjusted size of US$ 1384 million by 2030 with a CAGR of 3.5% during the forecast period 2024-2030
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Ovarian Cancer Diagnostics, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Ovarian Cancer Diagnostics by region & country, by Type, and by Application.
The Ovarian Cancer Diagnostics market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ovarian Cancer Diagnostics.
麻豆原创 Segmentation
By Company
Advanced Abrasives
Annon Piezo Technology Co. Limited.
APC International Ltd.
Bhalla Chemical Works Pvt. Ltd.
Central Electronics Limited
Ceradyne Inc.
Ceramic Magnetics Inc.
Ceramtec
Coorstek Inc.
CTS Corporation
Electro Ceramics (Thailand) Co. Ltd.
Friatec AG
GCI Electro-Ceramics Co.
Harris Corporation
Huntsman Corporation
Keltron Electro Ceramics Ltd.
Kyocera Corporation
Maruwa Co. Ltd.
Meggitt Sensing Systems
Morgan Advanced Materials
Rubicon Technology
Swiss Jewel Company
Taiyo Yuden
TCI Ceramics Inc.
Teledyne Reynolds Inc.
TRS Technologies Inc.
Segment by Type:
Titanate
Zirconia
Alumina
Others
Segment by Application
High dielectric capacitors
Volatile memories
Data and information storage
Energy storage and conversion
Environmental monitoring
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Ovarian Cancer Diagnostics manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Ovarian Cancer Diagnostics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Ovarian Cancer Diagnostics in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 麻豆原创 Overview
1.1 Ovarian Cancer Diagnostics Product Introduction
1.2 Global Ovarian Cancer Diagnostics 麻豆原创 Size Forecast
1.3 Ovarian Cancer Diagnostics 麻豆原创 Trends & Drivers
1.3.1 Ovarian Cancer Diagnostics Industry Trends
1.3.2 Ovarian Cancer Diagnostics 麻豆原创 Drivers & Opportunity
1.3.3 Ovarian Cancer Diagnostics 麻豆原创 Challenges
1.3.4 Ovarian Cancer Diagnostics 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Ovarian Cancer Diagnostics Players Revenue Ranking (2023)
2.2 Global Ovarian Cancer Diagnostics Revenue by Company (2019-2024)
2.3 Key Companies Ovarian Cancer Diagnostics Manufacturing Base Distribution and Headquarters
2.4 Key Companies Ovarian Cancer Diagnostics Product Offered
2.5 Key Companies Time to Begin Mass Production of Ovarian Cancer Diagnostics
2.6 Ovarian Cancer Diagnostics 麻豆原创 Competitive Analysis
2.6.1 Ovarian Cancer Diagnostics 麻豆原创 Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Ovarian Cancer Diagnostics Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ovarian Cancer Diagnostics as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Titanate
3.1.2 Zirconia
3.1.3 Alumina
3.1.4 Others
3.2 Global Ovarian Cancer Diagnostics Sales Value by Type
3.2.1 Global Ovarian Cancer Diagnostics Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Ovarian Cancer Diagnostics Sales Value, by Type (2019-2030)
3.2.3 Global Ovarian Cancer Diagnostics Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 High dielectric capacitors
4.1.2 Volatile memories
4.1.3 Data and information storage
4.1.4 Energy storage and conversion
4.1.5 Environmental monitoring
4.1.6 Others
4.2 Global Ovarian Cancer Diagnostics Sales Value by Application
4.2.1 Global Ovarian Cancer Diagnostics Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Ovarian Cancer Diagnostics Sales Value, by Application (2019-2030)
4.2.3 Global Ovarian Cancer Diagnostics Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Ovarian Cancer Diagnostics Sales Value by Region
5.1.1 Global Ovarian Cancer Diagnostics Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Ovarian Cancer Diagnostics Sales Value by Region (2019-2024)
5.1.3 Global Ovarian Cancer Diagnostics Sales Value by Region (2025-2030)
5.1.4 Global Ovarian Cancer Diagnostics Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Ovarian Cancer Diagnostics Sales Value, 2019-2030
5.2.2 North America Ovarian Cancer Diagnostics Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Ovarian Cancer Diagnostics Sales Value, 2019-2030
5.3.2 Europe Ovarian Cancer Diagnostics Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Ovarian Cancer Diagnostics Sales Value, 2019-2030
5.4.2 Asia Pacific Ovarian Cancer Diagnostics Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Ovarian Cancer Diagnostics Sales Value, 2019-2030
5.5.2 South America Ovarian Cancer Diagnostics Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Ovarian Cancer Diagnostics Sales Value, 2019-2030
5.6.2 Middle East & Africa Ovarian Cancer Diagnostics Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Ovarian Cancer Diagnostics Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Ovarian Cancer Diagnostics Sales Value
6.3 United States
6.3.1 United States Ovarian Cancer Diagnostics Sales Value, 2019-2030
6.3.2 United States Ovarian Cancer Diagnostics Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Ovarian Cancer Diagnostics Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Ovarian Cancer Diagnostics Sales Value, 2019-2030
6.4.2 Europe Ovarian Cancer Diagnostics Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Ovarian Cancer Diagnostics Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Ovarian Cancer Diagnostics Sales Value, 2019-2030
6.5.2 China Ovarian Cancer Diagnostics Sales Value by Type (%), 2023 VS 2030
6.5.3 China Ovarian Cancer Diagnostics Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Ovarian Cancer Diagnostics Sales Value, 2019-2030
6.6.2 Japan Ovarian Cancer Diagnostics Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Ovarian Cancer Diagnostics Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Ovarian Cancer Diagnostics Sales Value, 2019-2030
6.7.2 South Korea Ovarian Cancer Diagnostics Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Ovarian Cancer Diagnostics Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Ovarian Cancer Diagnostics Sales Value, 2019-2030
6.8.2 Southeast Asia Ovarian Cancer Diagnostics Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Ovarian Cancer Diagnostics Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Ovarian Cancer Diagnostics Sales Value, 2019-2030
6.9.2 India Ovarian Cancer Diagnostics Sales Value by Type (%), 2023 VS 2030
6.9.3 India Ovarian Cancer Diagnostics Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Advanced Abrasives
7.1.1 Advanced Abrasives Profile
7.1.2 Advanced Abrasives Main Business
7.1.3 Advanced Abrasives Ovarian Cancer Diagnostics Products, Services and Solutions
7.1.4 Advanced Abrasives Ovarian Cancer Diagnostics Revenue (US$ Million) & (2019-2024)
7.1.5 Advanced Abrasives Recent Developments
7.2 Annon Piezo Technology Co. Limited.
7.2.1 Annon Piezo Technology Co. Limited. Profile
7.2.2 Annon Piezo Technology Co. Limited. Main Business
7.2.3 Annon Piezo Technology Co. Limited. Ovarian Cancer Diagnostics Products, Services and Solutions
7.2.4 Annon Piezo Technology Co. Limited. Ovarian Cancer Diagnostics Revenue (US$ Million) & (2019-2024)
7.2.5 Annon Piezo Technology Co. Limited. Recent Developments
7.3 APC International Ltd.
7.3.1 APC International Ltd. Profile
7.3.2 APC International Ltd. Main Business
7.3.3 APC International Ltd. Ovarian Cancer Diagnostics Products, Services and Solutions
7.3.4 APC International Ltd. Ovarian Cancer Diagnostics Revenue (US$ Million) & (2019-2024)
7.3.5 Bhalla Chemical Works Pvt. Ltd. Recent Developments
7.4 Bhalla Chemical Works Pvt. Ltd.
7.4.1 Bhalla Chemical Works Pvt. Ltd. Profile
7.4.2 Bhalla Chemical Works Pvt. Ltd. Main Business
7.4.3 Bhalla Chemical Works Pvt. Ltd. Ovarian Cancer Diagnostics Products, Services and Solutions
7.4.4 Bhalla Chemical Works Pvt. Ltd. Ovarian Cancer Diagnostics Revenue (US$ Million) & (2019-2024)
7.4.5 Bhalla Chemical Works Pvt. Ltd. Recent Developments
7.5 Central Electronics Limited
7.5.1 Central Electronics Limited Profile
7.5.2 Central Electronics Limited Main Business
7.5.3 Central Electronics Limited Ovarian Cancer Diagnostics Products, Services and Solutions
7.5.4 Central Electronics Limited Ovarian Cancer Diagnostics Revenue (US$ Million) & (2019-2024)
7.5.5 Central Electronics Limited Recent Developments
7.6 Ceradyne Inc.
7.6.1 Ceradyne Inc. Profile
7.6.2 Ceradyne Inc. Main Business
7.6.3 Ceradyne Inc. Ovarian Cancer Diagnostics Products, Services and Solutions
7.6.4 Ceradyne Inc. Ovarian Cancer Diagnostics Revenue (US$ Million) & (2019-2024)
7.6.5 Ceradyne Inc. Recent Developments
7.7 Ceramic Magnetics Inc.
7.7.1 Ceramic Magnetics Inc. Profile
7.7.2 Ceramic Magnetics Inc. Main Business
7.7.3 Ceramic Magnetics Inc. Ovarian Cancer Diagnostics Products, Services and Solutions
7.7.4 Ceramic Magnetics Inc. Ovarian Cancer Diagnostics Revenue (US$ Million) & (2019-2024)
7.7.5 Ceramic Magnetics Inc. Recent Developments
7.8 Ceramtec
7.8.1 Ceramtec Profile
7.8.2 Ceramtec Main Business
7.8.3 Ceramtec Ovarian Cancer Diagnostics Products, Services and Solutions
7.8.4 Ceramtec Ovarian Cancer Diagnostics Revenue (US$ Million) & (2019-2024)
7.8.5 Ceramtec Recent Developments
7.9 Coorstek Inc.
7.9.1 Coorstek Inc. Profile
7.9.2 Coorstek Inc. Main Business
7.9.3 Coorstek Inc. Ovarian Cancer Diagnostics Products, Services and Solutions
7.9.4 Coorstek Inc. Ovarian Cancer Diagnostics Revenue (US$ Million) & (2019-2024)
7.9.5 Coorstek Inc. Recent Developments
7.10 CTS Corporation
7.10.1 CTS Corporation Profile
7.10.2 CTS Corporation Main Business
7.10.3 CTS Corporation Ovarian Cancer Diagnostics Products, Services and Solutions
7.10.4 CTS Corporation Ovarian Cancer Diagnostics Revenue (US$ Million) & (2019-2024)
7.10.5 CTS Corporation Recent Developments
7.11 Electro Ceramics (Thailand) Co. Ltd.
7.11.1 Electro Ceramics (Thailand) Co. Ltd. Profile
7.11.2 Electro Ceramics (Thailand) Co. Ltd. Main Business
7.11.3 Electro Ceramics (Thailand) Co. Ltd. Ovarian Cancer Diagnostics Products, Services and Solutions
7.11.4 Electro Ceramics (Thailand) Co. Ltd. Ovarian Cancer Diagnostics Revenue (US$ Million) & (2019-2024)
7.11.5 Electro Ceramics (Thailand) Co. Ltd. Recent Developments
7.12 Friatec AG
7.12.1 Friatec AG Profile
7.12.2 Friatec AG Main Business
7.12.3 Friatec AG Ovarian Cancer Diagnostics Products, Services and Solutions
7.12.4 Friatec AG Ovarian Cancer Diagnostics Revenue (US$ Million) & (2019-2024)
7.12.5 Friatec AG Recent Developments
7.13 GCI Electro-Ceramics Co.
7.13.1 GCI Electro-Ceramics Co. Profile
7.13.2 GCI Electro-Ceramics Co. Main Business
7.13.3 GCI Electro-Ceramics Co. Ovarian Cancer Diagnostics Products, Services and Solutions
7.13.4 GCI Electro-Ceramics Co. Ovarian Cancer Diagnostics Revenue (US$ Million) & (2019-2024)
7.13.5 GCI Electro-Ceramics Co. Recent Developments
7.14 Harris Corporation
7.14.1 Harris Corporation Profile
7.14.2 Harris Corporation Main Business
7.14.3 Harris Corporation Ovarian Cancer Diagnostics Products, Services and Solutions
7.14.4 Harris Corporation Ovarian Cancer Diagnostics Revenue (US$ Million) & (2019-2024)
7.14.5 Harris Corporation Recent Developments
7.15 Huntsman Corporation
7.15.1 Huntsman Corporation Profile
7.15.2 Huntsman Corporation Main Business
7.15.3 Huntsman Corporation Ovarian Cancer Diagnostics Products, Services and Solutions
7.15.4 Huntsman Corporation Ovarian Cancer Diagnostics Revenue (US$ Million) & (2019-2024)
7.15.5 Huntsman Corporation Recent Developments
7.16 Keltron Electro Ceramics Ltd.
7.16.1 Keltron Electro Ceramics Ltd. Profile
7.16.2 Keltron Electro Ceramics Ltd. Main Business
7.16.3 Keltron Electro Ceramics Ltd. Ovarian Cancer Diagnostics Products, Services and Solutions
7.16.4 Keltron Electro Ceramics Ltd. Ovarian Cancer Diagnostics Revenue (US$ Million) & (2019-2024)
7.16.5 Keltron Electro Ceramics Ltd. Recent Developments
7.17 Kyocera Corporation
7.17.1 Kyocera Corporation Profile
7.17.2 Kyocera Corporation Main Business
7.17.3 Kyocera Corporation Ovarian Cancer Diagnostics Products, Services and Solutions
7.17.4 Kyocera Corporation Ovarian Cancer Diagnostics Revenue (US$ Million) & (2019-2024)
7.17.5 Kyocera Corporation Recent Developments
7.18 Maruwa Co. Ltd.
7.18.1 Maruwa Co. Ltd. Profile
7.18.2 Maruwa Co. Ltd. Main Business
7.18.3 Maruwa Co. Ltd. Ovarian Cancer Diagnostics Products, Services and Solutions
7.18.4 Maruwa Co. Ltd. Ovarian Cancer Diagnostics Revenue (US$ Million) & (2019-2024)
7.18.5 Maruwa Co. Ltd. Recent Developments
7.19 Meggitt Sensing Systems
7.19.1 Meggitt Sensing Systems Profile
7.19.2 Meggitt Sensing Systems Main Business
7.19.3 Meggitt Sensing Systems Ovarian Cancer Diagnostics Products, Services and Solutions
7.19.4 Meggitt Sensing Systems Ovarian Cancer Diagnostics Revenue (US$ Million) & (2019-2024)
7.19.5 Meggitt Sensing Systems Recent Developments
7.20 Morgan Advanced Materials
7.20.1 Morgan Advanced Materials Profile
7.20.2 Morgan Advanced Materials Main Business
7.20.3 Morgan Advanced Materials Ovarian Cancer Diagnostics Products, Services and Solutions
7.20.4 Morgan Advanced Materials Ovarian Cancer Diagnostics Revenue (US$ Million) & (2019-2024)
7.20.5 Morgan Advanced Materials Recent Developments
7.21 Rubicon Technology
7.21.1 Rubicon Technology Profile
7.21.2 Rubicon Technology Main Business
7.21.3 Rubicon Technology Ovarian Cancer Diagnostics Products, Services and Solutions
7.21.4 Rubicon Technology Ovarian Cancer Diagnostics Revenue (US$ Million) & (2019-2024)
7.21.5 Rubicon Technology Recent Developments
7.22 Swiss Jewel Company
7.22.1 Swiss Jewel Company Profile
7.22.2 Swiss Jewel Company Main Business
7.22.3 Swiss Jewel Company Ovarian Cancer Diagnostics Products, Services and Solutions
7.22.4 Swiss Jewel Company Ovarian Cancer Diagnostics Revenue (US$ Million) & (2019-2024)
7.22.5 Swiss Jewel Company Recent Developments
7.23 Taiyo Yuden
7.23.1 Taiyo Yuden Profile
7.23.2 Taiyo Yuden Main Business
7.23.3 Taiyo Yuden Ovarian Cancer Diagnostics Products, Services and Solutions
7.23.4 Taiyo Yuden Ovarian Cancer Diagnostics Revenue (US$ Million) & (2019-2024)
7.23.5 Taiyo Yuden Recent Developments
7.24 TCI Ceramics Inc.
7.24.1 TCI Ceramics Inc. Profile
7.24.2 TCI Ceramics Inc. Main Business
7.24.3 TCI Ceramics Inc. Ovarian Cancer Diagnostics Products, Services and Solutions
7.24.4 TCI Ceramics Inc. Ovarian Cancer Diagnostics Revenue (US$ Million) & (2019-2024)
7.24.5 TCI Ceramics Inc. Recent Developments
7.25 Teledyne Reynolds Inc.
7.25.1 Teledyne Reynolds Inc. Profile
7.25.2 Teledyne Reynolds Inc. Main Business
7.25.3 Teledyne Reynolds Inc. Ovarian Cancer Diagnostics Products, Services and Solutions
7.25.4 Teledyne Reynolds Inc. Ovarian Cancer Diagnostics Revenue (US$ Million) & (2019-2024)
7.25.5 Teledyne Reynolds Inc. Recent Developments
7.26 TRS Technologies Inc.
7.26.1 TRS Technologies Inc. Profile
7.26.2 TRS Technologies Inc. Main Business
7.26.3 TRS Technologies Inc. Ovarian Cancer Diagnostics Products, Services and Solutions
7.26.4 TRS Technologies Inc. Ovarian Cancer Diagnostics Revenue (US$ Million) & (2019-2024)
7.26.5 TRS Technologies Inc. Recent Developments
8 Industry Chain Analysis
8.1 Ovarian Cancer Diagnostics Industrial Chain
8.2 Ovarian Cancer Diagnostics Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Ovarian Cancer Diagnostics Sales Model
8.5.2 Sales Channel
8.5.3 Ovarian Cancer Diagnostics Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
Advanced Abrasives
Annon Piezo Technology Co. Limited.
APC International Ltd.
Bhalla Chemical Works Pvt. Ltd.
Central Electronics Limited
Ceradyne Inc.
Ceramic Magnetics Inc.
Ceramtec
Coorstek Inc.
CTS Corporation
Electro Ceramics (Thailand) Co. Ltd.
Friatec AG
GCI Electro-Ceramics Co.
Harris Corporation
Huntsman Corporation
Keltron Electro Ceramics Ltd.
Kyocera Corporation
Maruwa Co. Ltd.
Meggitt Sensing Systems
Morgan Advanced Materials
Rubicon Technology
Swiss Jewel Company
Taiyo Yuden
TCI Ceramics Inc.
Teledyne Reynolds Inc.
TRS Technologies Inc.
听
听
*If Applicable.
